bioAffinity Technologies(BIAF) - 2023 Q4 - Annual Report

CyPathLung has not been tested directly against its competitors' products, but a comparison of the published performance numbers suggests CyPath Lung is among the highest performing tests on the market. Furthermore, CyPath Lung is noninvasive – not even requiring a needle stick – and cost effective, and processing and analysis procedures are easy to perform. 11 Published data and the results of clinical trials allow us to group lung cancer diagnostic tests into three categories: (1) balanced tests;( 2) rule ...